Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Gray Media Inc
GTN.A
$612M
| $136K | ﹤0.01% |
15,000
-300
| -2% | -$2.43K |
|
3127
Cohen & Co
COHN
$38.7M
| $136K | ﹤0.01% |
+15,300
| New | +$130K |
|
3128
Castor Maritime
CTRM
$20.2M
| $136K | ﹤0.01% |
29,469
+8,400
| +40% | +$33.1K |
|
|
CMCM
3129
Cheetah Mobile
CMCM
$93.7M
| $134K | ﹤0.01% |
33,545
| – | – |
|
|
UDMY
3130
DELISTED
Udemy
UDMY
| $133K | ﹤0.01% |
+15,400
| New | +$146K |
|
3131
Armata Pharmaceuticals
ARMP
$158M
| $133K | ﹤0.01% |
48,196
-3,200
| -6% | -$9.13K |
|
3132
Coursera
COUR
$1.48B
| $132K | ﹤0.01% |
18,400
-1,136,000
| -98% | -$10.8M |
|
|
JFIN
3133
Jiayin Group
JFIN
$121M
| $132K | ﹤0.01% |
21,300
-20,100
| -49% | -$132K |
|
|
ONCT
3134
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $131K | ﹤0.01% |
17,205
+300
| +2% | +$2.58K |
|
3135
Context Therapeutics
CNTX
$46.5M
| $131K | ﹤0.01% |
65,200
+25,300
| +63% | +$43.6K |
|
|
SCNX
3136
Scienture Holdings
SCNX
$18.9M
| $131K | ﹤0.01% |
11,700
-21,682
| -65% | -$158K |
|
3137
Central Plains Bancshares
CPBI
$87.6M
| $130K | ﹤0.01% |
12,900
| – | – |
|
3138
Imunon
IMNN
$6.64M
| $129K | ﹤0.01% |
8,534
+422
| +5% | +$7.43K |
|
|
ICD
3139
DELISTED
Independence Contract Drilling, Inc.
ICD
| $128K | ﹤0.01% |
98,510
+10,500
| +12% | +$17.2K |
|
3140
Candel Therapeutics
CADL
$865M
| $128K | ﹤0.01% |
20,600
-36,305
| -64% | -$272K |
|
|
OCFT
3141
DELISTED
OneConnect Financial Technology
OCFT
| $128K | ﹤0.01% |
80,760
+800
| +1% | +$1.6K |
|
|
UROY
3142
Uranium Royalty Corp
UROY
$1.55B
| $126K | ﹤0.01% |
56,000
-351,900
| -86% | -$874K |
|
3143
Genelux
GNLX
$121M
| $124K | ﹤0.01% |
63,800
-36,600
| -36% | -$124K |
|
|
YARW
3144
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
| $124K | ﹤0.01% |
1,262
-350
| -22% | -$43.6K |
|
3145
SR Bancorp
SRBK
$148M
| $124K | ﹤0.01% |
13,427
-11,873
| -47% | -$109K |
|
|
STRM
3146
DELISTED
Streamline Health Solutions
STRM
| $122K | ﹤0.01% |
17,718
-2,687
| -13% | -$15.9K |
|
3147
Vroom Inc
VRM
$52.1M
| $122K | ﹤0.01% |
13,126
-1,400
| -10% | -$15.6K |
|
3148
MiNK Therapeutics
INKT
$56.6M
| $121K | ﹤0.01% |
12,784
+2,261
| +21% | +$22K |
|
|
EGIO
3149
DELISTED
Edgio, Inc. Common Stock
EGIO
| $121K | ﹤0.01% |
11,057
-900
| -8% | -$9.53K |
|
3150
Blue Ridge Bankshares
BRBS
$339M
| $121K | ﹤0.01% |
46,200
-33,851
| -42% | -$94.5K |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.